drugset / Trial / NCT02248818
AZD8108 SAD/MAD in Healthy Volunteers
RandomizedParallel-groupDouble-blindBasic science
Summary
This is a randomized, double-blind, placebo-controlled study of single and multiple ascending dosage levels of AZD8108 in healthy volunteers. The study includes an up to 28-day screening period, an in-house period during which AZD8108 or placebo will be administered orally as a solution, and a 4- to 10-day follow-up period after discharge.
Timeline
- Start
- 2014-11
- Primary completion
- 2015-09
- Completion
- 2015-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD8108 | Unknown | — | Oral |
Indications
No indication recorded.